| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesiology, Niigata University School of Medicine; and
Department of Cellular Neurobiology, Brain Research Institute, Niigata University, Niigata, Japan
Address correspondence and reprint requests to Tomohiro Yamakura, MD, Department of Anesthesiology, Niigata University School of Medicine, 1-757 Asahimachi, Niigata 951-8510, Japan. Address e-mail to yamakura{at}med.niigata-u.ac.jp
The effects of S(+)- and R()-ketamine on heteromeric N-methyl-D-aspartate receptor channels were investigated on the
1/
1,
2/
1,
3/
1, and
4/
1 channels expressed in Xenopus oocytes. S(+)-ketamine inhibited all four
/
channels more effectively than R()-ketamine. The inhibitor concentrations for half-control response for S(+)-ketamine were quite similar among the four channels with 0.440.56 µM. However, the inhibitor concentrations for half-control response for R()-ketamine varied slightly among the four channels with 1.0 µM for
2/
1 and
3/
1 channels and 1.92.0 µM for
1/
1 and
4/
1 channels. Thus, the potency ratio of S(+)- and R()-ketamine for heteromeric channels was only slightly different among the
/
channels.
Implications: The potency order and ratio of ketamine isomers for inhibition of N-methyl-D-aspartate receptor channels may not be so different between the brain region and the developmental stage.
This article has been cited by other articles:
![]() |
X. Chen, S. Shu, and D. A. Bayliss HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine J. Neurosci., January 21, 2009; 29(3): 600 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Nagels, R. Demeyere, J. Van Hemelrijck, E. Vandenbussche, K. Gijbels, and E. Vandermeersch Evaluation of the Neuroprotective Effects of S(+)-Ketamine During Open-Heart Surgery Anesth. Analg., June 1, 2004; 98(6): 1595 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Callahan, J. D. Au, M. Paul, C. Liu, and C. S. Yost Functional Inhibition by Methadone of N-Methyl-D-Aspartate Receptors Expressed in Xenopus Oocytes: Stereospecific and Subunit Effects Anesth. Analg., March 1, 2004; 98(3): 653 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Scheufler, C. Thees, J. Nadstawek, and J. Zentner S(+)-Ketamine Attenuates Myogenic Motor-Evoked Potentials at or Distal to the Spinal {alpha}-Motoneuron Anesth. Analg., January 1, 2003; 96(1): 238 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Reeves, D. E. Lindholm, P. S. Myles, H. Fletcher, and J. O. Hunt Adding Ketamine to Morphine for Patient-Controlled Analgesia After Major Abdominal Surgery: A Double-Blinded, Randomized Controlled Trial Anesth. Analg., July 1, 2001; 93(1): 116 - 120. [Abstract] [Full Text] [PDF] |
||||
|